✦ LIBER ✦

Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients

✍ Scribed by Han, Sae-Won; Kim, Tae-You; Lee, Kyung-Hun; Hwang, Pil Gyu; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue

Book ID: 119319461
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 332 KB
Volume: 54
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2006.07.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor polymor

Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib

✍ Liu, G; Gurubhagavatula, S; Zhou, W; Wang, Z; Yeap, B Y; Asomaning, K; Su, L; He 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Predictive and Prognostic Impact of Epid

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer Patients Treated With Gefitinib

✍ Han, S.-W. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 132 KB

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese

✍ Uramoto, Hidetaka; Sugio, Kenji; Oyama, Tsunehiro; Ono, Kenji; Sugaya, Masakazu; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 121 KB

The impact of epidermal growth factor re

The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer

✍ Shuji Ichihara; Shinichi Toyooka; Yoshiro Fujiwara; Katsuyuki Hotta; Hisayuki Sh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 403 KB 👁 2 views

## Abstract We investigated the relationships between genetic factors and clinical outcome in Japanese non‐small‐cell lung cancer (NSCLC) patients treated with gefitinib. Ninety‐eight NSCLC patients who had been treated with gefitinib, were screened for mutations in epidermal growth factor receptor

Activating Mutations in the Epidermal Gr

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

✍ Lynch, Thomas J.; Bell, Daphne W.; Sordella, Raffaella; Gurubhagavatula, Sarada; 📂 Article 📅 2004 🏛 Massachusetts Medical Society 🌐 English ⚖ 442 KB

Prospective phase II study of gefitinib

Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations

✍ Sugio, Kenji; Uramoto, Hidetaka; Onitsuka, Takamitsu; Mizukami, Makiko; Ichiki, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 181 KB